Fielmann GROUP AG FIE.DE
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Business Model#
What the company does and how it earns its money; written AI-editorially, exclusively from the company's original reports, without any assessment of our own.
Fielmann Group is a vertically integrated optical and hearing care retailer headquartered in Hamburg, Germany. The group designs, manufactures, and retails eyeglasses, contact lenses, and hearing aids through an owned store network spanning Germany and international markets including Austria, Switzerland, Poland, Italy, Spain, the Netherlands, Luxembourg, and the United States. Revenue is generated primarily at the point of sale across its retail locations, while vertically integrated manufacturing and centralized procurement support the group's characteristically high gross margins. Fielmann entered the United States through the acquisitions of Shopko Optical and SVS Vision, extending its footprint beyond the European core. The group's growth strategy centres on accelerated new store openings and selective bolt-on acquisitions in established and adjacent markets, as demonstrated by the H1/2026 acquisition of ten optical and hearing care businesses in Luxembourg and the FY2026 target of 70 new store openings, tripling the prior year's expansion pace.
Current Status#
Summary of the most recent reporting period: core figures, drivers and management statements; written editorially from the current original report, every figure backed by a source number.
Price & Chart#
Interactive price chart (TradingView) and the trend of key figures from the core tables. The price chart loads only after a click; at that point a connection to TradingView is established.
Daily candles with news and earnings markers. Loads only on click.
Share-Price Drivers#
Factors the company itself names as material for its business development (IR-based); reproduced neutrally, no price forecast and no assessment of our own.
Revenue rose to €634.9m in 2026-Q2 from €620.8m a year earlier with adjusted operating income of €81.1m and diluted EPS of €0.67 vs €0.63, and change flags show growth accelerating, profitability improving and guidance confirmed (130)
Largest segment at €754.9m in 2026-H1 at roughly 23% margin, broadly flat year on year, anchoring group revenue (30)
Switzerland €126.2m (+7%, ~30% margin) and Spain €109.6m (+7%, ~20% margin) in 2026-H1 (30)
North America revenue €137.8m in 2026-H1 was down ~3% at a lower ~10% margin, following the 2024 acquisitions of Shopko Optical and SVS Vision and the US-platform business-model transformation (30, 24, 16, 20)
Acquisition of ten Luxembourg optical and hearing-aid companies effective 2026-01-01, plus buyout of remaining Óptica del Penedés stake (30, 27, 24)
Rollout of eye-screening services expanded toward nearly 700 branches in Germany, Austria and Switzerland, with a minority investment and partnership in Ocumeda AG (24)
33 new hearing-aid studios opened in 2025 and the omnichannel platform rollout was reported as launched (24)
Übrige segment €65.0m in 2026-H1, up ~10% at ~18% margin (30)
Sector trend: Group KPIs point to accelerating demand with expanding profitability, as revenue and diluted EPS rose year on year while adjusted operating margin held around 12-13% and net debt fell to €34.7m from €91.5m (130). Regional margins vary widely, from ~30% in Switzerland and ~23% in Germany down to ~10% in North America (30).
Event Timeline#
This timeline collects the material events from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements. Events are grouped by quarter (most recent first); the grey tag before each event names the event type, the date is the publication date of the source. Management quotes open the quarter block as direct quotes. Per quarter we show the three most defining events; more can be expanded per quarter, older years are collapsed. Every event carries its source as a superscript, clickable number.
2026 · 6 events
2026-Q2 · Apr – Jun 2026
International revenue accelerated in H1/2026, led by Spain (+7.4%) and the United States (+3.3% currency-adjusted) 30
Gross margin expanded to 80.1% in H1/2026, driven by improved cost base and sustained cost discipline 30
FY2026 guidance confirmed: revenue EUR 2.50-2.55 billion, adj. EBITDA margin 22-23%, adj. EBT margin approximately 12% 30
2026-Q1 · Jan – Mar 2026
Q1 group revenue +1.3% to EUR 613 million, constrained by adverse weather conditions and public transport strikes in Germany 27
FY2026 guidance issued: group revenue EUR 2.55-2.60 billion, adj. EBITDA margin approximately 23%, adj. EBT margin 12-13% 27
Luxembourg optical chain first-consolidated, contributing EUR 4 million to group revenue in Q1 27
2025 · 12 events
2025-H1 · Jan – Jun 2025
US adj. EBITDA margin 14.9% vs. 2.2% prior year; prior year depressed by integration and setup costs following Shopko Optical acquisition 26
H1 group total performance +12.3% to €1,224 million; organic growth +4.4%, Shopko Optical consolidation contributing +7.9% 26
Vision 2035 published at AGM: 2030 targets of group revenue ~€3.8-4.2 billion and adj. EBITDA margin ~25% 26
2025-Q4 · Oct – Dec 2025
Net income +33% to record €205.5 million; EPS €2.43 (+34.3%); FCF +€304.3 million to €383.2 million 24
Vision 2025 completed (group revenue +~70% over 6 years); Vision 2035 launched targeting ~€4 billion revenue and ~25% adj. EBITDA margin by 2030 24
2025-Q3 · Jul – Sep 2025
US platform 9M adj. EBITDA margin approximately doubled to 13.9%; prior year depressed by Shopko integration and setup costs 20
9M adj. EBITDA margin 23.6% vs. 21.9% prior year, within FY2025 target corridor 20
FY2025 outlook confirmed: total performance ~€2.5 billion, adj. EBITDA margin ~24% 20
2025-Q1 · Jan – Mar 2025
Q1 revenue +12.5% to €603 million; eyewear volume +4.9%; international markets +28.0% with US becoming second-largest market 19
Adj. EBITDA +28.2% to €146 million, margin 24.2%; European segment margin 25.6% reached Vision 2025 target 19
2024 · 13 events
2024-Q4 · Oct – Dec 2024
FY2024 group revenue rose 14.9% to €2,265m, with 7% organic growth and 8% from acquisitions; North American revenue grew from €32.4m to €196.4m following Shopko Optical 16
Adjusted EBITDA margin improved approximately 1.5 percentage points to 21.7% at group level and approximately 2.1 percentage points to 22.8% in Europe 16
2024-Q3 · Jul – Sep 2024
Adjusted EBITDA margin in Europe improved 1.1 percentage points to 23.6% through nine months; adjusted EBITDA rose 12.9% to €379m 12
Shopko Optical acquisition completed for US$287.5m, adding 144 stores across 13 US states and establishing Fielmann's position in the Upper Midwest 12
2024-Q2 · Apr – Jun 2024
H1 group revenue rose 11% to €1,081m, with 5% organic growth and 6% from US acquisition 18
H1 EBITDA rose 14% to €237m with EBITDA margin improving to 21.7%; EBT rose 17% to €127m with EBT margin expanding to 11.6% 18
Full-year 2024 guidance confirmed: double-digit revenue growth and higher EBITDA and EBT expected; European EBITDA margin target of approximately 23% for 2024 reiterated 18
2023 · 12 events
2023-Q4 · Oct – Dec 2023
International revenue +23.5% to EUR 625.3M (35% of group); e-commerce crossed EUR 100M for the first time (+17%); German corrective eyewear market share at record 55% 8
EBITDA margin expanded from 19.3% to 20.8%, supported by revenue scale and cost savings programme 8
Net position shifted from net cash of EUR 101.4M at H1 to net debt of EUR 74.2M at year-end, driven by EUR 268.4M in M&A and expansion investments 116
2023-Q3 · Jul – Sep 2023
Nine-month group revenue +13.7% to EUR 1.50B; international markets +20.8% year-on-year; digital channels +16.2% 4
Augen-Check-Up preventive eye-care service launched in collaboration with Ocumeda; over 14,000 customers registered 4
SVS Vision -- 82 optical stores in nine US states -- acquired effective 1 September 2023, establishing Fielmann's first North American brick-and-mortar network 4
2023-Q2 · Apr – Jun 2023
Eyevious Style Inc. (Canada) and Eye Style of America Ltd. (USA) acquired, integrating e-commerce platform Befitting and insurance technology as initial North American entry vehicle 8
H1 EBITDA rose to EUR 208.2M (prior year: EUR 171.4M); H1 pre-tax profit reached EUR 108.1M (prior year: EUR 89.1M) 10
H1 e-commerce revenue +28% year-on-year; online glasses purchase launched in Germany in Q2 2023 10
Key Figures (€m)#
The company's core financial figures in three views, one below the other: fiscal years (as reported; after restatements the table shows the most recent filing version, marked), half-years (6-month basis, H2 = second half on its own) and quarters (3-month basis, not cumulative). Each row is one period, most recent first. Values with a dotted underline are clickable and show the raw value, the exact source location, the scale evidence and the source; derived values additionally show their formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Revenue | Op. income | Op. income (adj.) | Net income | EPS (€) | EBITDA (adj.) | OCF | Source |
|---|---|---|---|---|---|---|---|---|
| FY2025 | 2,435.3 | – | – | 203.7 | 2.43 | 580.7 | 496 | 124 |
| FY2024 | 2,266.9 | 218.8 | 240.1 | 152.4 | 1.81 | 491.9 | 410.1 | 16 |
| FY2023 | 1,970.9 | – | 192.8~ | 124.8 | 1.49 | 398.6 | 282.8 | 1 |
Half-years
| Period | Published | Revenue | Op. income | Op. income (adj.) | Net income | EPS (€) | EBITDA (adj.) | FCF | Cash | Net Debt | Net Debt/EBITDA (x) | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-H1* | 2026-08-27 | 1,248 | 158.4 | 162.3~ | 111.5 | 1.33 | 295.7 | 145.3 | 264.9 | 34.7 | 0.1x (LTM)~ | 130 |
| 2025-H2* | 2026-04-15 | 1,219.5 | – | – | 100.1 | 1.19* | 288.8 | 187.4 | 222.5 | 61.7 | 0.1x (LTM) | 24 |
| 2025-H1* | 2025-08-28 | 1,225.8 | 153.9 | 159.7~ | 107.4 | 1.28 | 291.9 | 195.8 | 193.2 | 91.5 | 0.2x (LTM) | 126 |
| 2024-H2* | 2025-04-17 | 1,185.1 | 96.6 | – | 67.7 | 0.80* | 261.9 | 163.9 | 94.3 | 219.6 | 0.5x (LTM) | 16 |
| 2024-H1* | 2024-08-29 | 1,081.8 | 122.2 | 122.1 | 84.7 | 1.01 | 230 | 166.5 | 338 | -39.7 | – | 118 |
| 2023-H2* | 2024-04-18 | 1,000 | – | – | 54.9 | 0.66* | – | 91 | 58.9 | 74.2 | – | 1 |
| 2023-H1* | 2023-06-30 | 970.9 | 108.1 | – | 69.9 | 0.83 | – | 107.8 | 103.1 | -101.4~ | – | 118 |
Quarters
| Period | Published | Revenue | Op. income | Op. income (adj.) | Net income | EPS (€) | EBITDA (adj.) | FCF | Cash | Net Debt | Net Debt/EBITDA (x) | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q2* | 2026-08-27 | 634.9 | 79.1 | 81.1~ | 55.8 | 0.67 | 146.7 | – | 264.9 | 34.7 | 0.1x (LTM)~ | 130 |
| 2026-Q1* | 2026-03-31 | 613.1 | 79.3 | 81.2 | 55.7 | 0.66* | 149 | – | – | – | – | 127 |
| 2025-Q4* | 2026-04-15 | 589.3 | – | – | 44.4 | 0.53* | 146.7 | – | 222.5 | 61.7 | 0.1x (LTM) | 24 |
| 2025-Q3* | 2025-09-30 | 620.2 | 75.8 | – | 51.9 | 0.62 | 142.1 | – | – | – | – | 120 |
| 2025-Q2* | 2026-08-27 | 620.8 | 76 | 80~ | 52.9 | 0.63 | 143.9 | – | 193.2 | 91.5 | 0.2x (LTM) | 130 |
| 2025-Q1 | 2025-03-31 | 605 | 78 | 79.7 | 54.6 | 0.62 | 148 | – | – | – | – | 19 |
| 2024-Q4* | 2025-04-17 | 583 | 38.5 | – | 27.3 | 0.32* | 121.9 | – | 94.3 | 219.6 | 0.5x (LTM) | 16 |
| 2024-Q3* | 2024-09-30 | 603.7 | 58.1 | – | 40.4 | 0.48 | 140 | – | – | – | – | 12 |
| 2024-Q2* | 2024-08-29 | 551.8 | 64.8 | – | 43.3 | 0.52 | 116.4 | – | 338 | -39.7 | – | 18 |
| 2024-Q1 | 2024-03-31 | 536 | 60 | 60.8 | 42.2 | 0.49 | 113.6 | – | – | – | – | 111 |
| 2023-Q4* | 2024-04-18 | 473.6 | – | – | 12.6 | 0.15* | 62.9 | – | 58.9 | 74.2 | – | 1 |
| 2023-Q3 | 2024-09-30 | 521 | 65 | – | 43.8 | 0.50 | – | – | – | – | – | 12 |
| 2023-Q2* | 2023-06-30 | 493.2 | 49.8 | – | 33.5 | 0.38 | – | 28.3 | 103.1 | -101.4~ | – | 18 |
| 2023-Q1* | 2023-03-31 | 484 | 58 | 59 | 38.3 | 0.47 | 106 | 79.5 | 112.2 | -110.7~ | – | 3 |
Balance Sheet & Cash Flow (€m)#
Point-in-time balance sheet items (e.g. cash, financial debt) and cash flow items (operating cash flow, investments/capex) per fiscal year, half-year and quarter. Balance sheet values are as of the period end, flow items cover the period. Derived values are marked and are calculated, for example, as: net debt = financial debt − cash; free cash flow = operating cash flow − capex; the click popover shows formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
Fiscal years
| Period | Published | Cash | Debt | Net Debt | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|
| FY2025 | 2026-04-15 | 222.5 | 284.2 | 61.7 | 496 | 112.8 | 383.2 | 124 |
| FY2024 | 2025-04-17 | 94.3 | 313.9 | 219.6 | 410.1 | 79.7 | 330.4 | 16 |
| FY2023 | 2024-04-18 | 58.9 | 133.1 | 74.2 | 282.8 | 84 | 198.8 | 1 |
Half-years
| Period | Published | Cash | Debt | Net Debt | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|
| 2026-H1 | 2026-08-27 | 264.9 | 299.6 | 34.7 | 188.4 | 43.1 | 145.3 | 130 |
| 2025-H2 | 2026-04-15 | 222.5 | 284.2 | 61.7 | 260.2 | 72.9 | 187.4 | 24 |
| 2025-H1 | 2025-08-28 | 193.2 | 284.8 | 91.5 | 235.8 | 39.9 | 195.8 | 126 |
| 2024-H2 | 2025-04-17 | 94.3 | 313.9 | 219.6 | 212.5 | 48.6 | 163.9 | 16 |
| 2024-H1 | 2024-08-29 | 338 | 298.3 | -39.7 | 197.6 | 31.2 | 166.5 | 118 |
| 2023-H2 | 2024-04-18 | 58.9 | 133.1 | 74.2 | 137.8 | 46.9 | 91 | 1 |
| 2023-H1 | 2023-06-30 | 103.1 | 1.7~ | -101.4~ | 145 | 37.1 | 107.8 | 118 |
Quarters
| Period | Published | Cash | Debt | Net Debt | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|
| 2026-Q2 | 2026-08-27 | 264.9 | 299.6 | 34.7 | – | – | – | 130 |
| 2025-Q4 | 2026-04-15 | 222.5 | 284.2 | 61.7 | – | – | – | 24 |
| 2025-Q2 | 2026-08-27 | 193.2 | 284.8 | 91.5 | – | – | – | 130 |
| 2024-Q4 | 2025-04-17 | 94.3 | 313.9 | 219.6 | – | – | – | 16 |
| 2024-Q2 | 2024-08-29 | 338 | 298.3 | -39.7 | – | – | – | 18 |
| 2023-Q4 | 2024-04-18 | 58.9 | 133.1 | 74.2 | – | – | – | 1 |
| 2023-Q2 | 2023-06-30 | 103.1 | 1.7~ | -101.4~ | 49.3 | 21 | 28.3 | 18 |
| 2023-Q1 | 2023-03-31 | 112.2 | 1.6~ | -110.7~ | 95.7 | 16.1 | 79.5 | 3 |
Revenue by Type (as of 2026-Q2 · EURm · 9/12)#
Revenue split by segment or product type, exactly as the company itself reports it. The basis is stated next to each value (3, 6 or 12 months); segment totals can deviate from group revenue (reconciliation/consolidation items). If the company changes its segment structure, older structures are kept in the expandable part. Rows in grey are no longer reported separately by the company; they show the last available figures and are never extrapolated.
| Segment | Since | Period | Basis | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|---|---|
| North America | FY2023 | 2026-H1 | 6M | 137.8 | -3% | 10% | 30 |
| Other | 2023-H1 | 2026-H1 | 6M | 65 | 10% | 18% | 30 |
| Germany | 2023-Q1 | 2026-H1 | 6M | 754.9 | 0% | 23% | 30 |
| Switzerland | 2023-Q1 | 2026-H1 | 6M | 126.2 | 7% | 30% | 30 |
| Spain | 2023-Q1 | 2026-H1 | 6M | 109.6 | 7% | 20% | 30 |
| Austria | 2023-Q1 | 2026-H1 | 6M? | 54.5 | 1% | 15% | 30 |
| North America (US Platform) | 2025-Q3 | 2025-Q3 | 9M | 233 | 69% | 13% | 20 |
| Other regions | FY2024 | FY2025 | 12M | 142.2 | 4% | 21% | 24 |
| Poland | 2024-Q3 | 2025-Q1 | 3M | 34.3 | 17.6% | 22.9% | 19 |
| Other | FY2023 | FY2023 | 12M | 126.9 | – | – | 8 |
| USA | FY2023 | FY2023 | 12M | 32.4 | – | – | 1 |
| Other markets | 2023-Q1 | 2023-Q1 | 3M | 27.6 | 31% | – | 3 |
Products & M&A (14/26 active+recent)#
Product announcements from the reports; market launches, approvals, partnerships; with first mention (date) and source. “Active/current” means: still mentioned in the most recent reports; what the company no longer mentions moves to the expandable part but is never deleted. Rows in grey are discontinued products.
| Product/Line | Since | Status | Source |
|---|---|---|---|
| Production & logistics site Chomutov Czech Republic | 2025-12 | Launched | 8 |
| Office 2025 Head Office | 2025-09 | Launched | 8 |
| Business Model Transformation US platform | 2025-09 | Launched | 20 |
| Vision 2035 and 2030 targets publication | 2025-07 | Launched | 26 |
| Vision 2035 & strategy to 2030 | 2025-07 | Launched | 16 |
| Eye Health Check-Up rollout to additional European markets | 2025-03 | Launched | 19 |
| Fielmann Group AG headquarters in Hamburg | 2025 | Launched | 24 |
| Vision 2035 launched | 2025 | Launched | 24 |
| Schuldscheindarlehen | 2025 | Launched | 24 |
| Production and logistics facility Chomutov | 2025 | Launched | 24 |
| Ocumeda AG partnership for eye care services | 2025 | Launched | 24 |
| Eye care services expansion to nearly 700 locations in Germany, Austria, Switzerland | 2025 | Launched | 24 |
| 33 new hearing aid studios opened | 2025 | Launched | 24 |
| Omnichannel platform rollout | 2023-03 | Launched | 24 |
| Online consultation for eyeglass frames with AI | 2024 | Launched | 16 |
| Progressive lens simulation (ADD-Vision) | 2024 | Launched | 16 |
| Guided complaint handling in ZenIT | 2024 | Launched | 16 |
| Expansion in Czech Republic | 2023-03 | Launched | 3 |
| E-commerce prescription eyewear offering expansion | 2023-01 | Launched | 8 |
| Sustainable Collection with recycled acetate | 2023 | Launched | 1 |
| New store openings | 2023 | Launched | 8 |
| Logistics centre Chomutov | 2023 | Launched | 8 |
| ISCC PLUS certification | 2023 | Launched | 1 |
| Hearing acoustics studios expansion | 2023 | Launched | 1 |
| Eye Check-Up Rollout (7×) | 2023 | Launched | 8 |
| New collection with bio-based acetate | 2022 | Launched | 1 |
M&A (31)#
All recorded acquisitions (purchases) and divestitures/exits with date, short description and source; deliberately including smaller transactions that summaries often miss. Purchase prices appear only where the company itself has disclosed them. Rows in grey are cancelled transactions; the cancellation date is shown in the row.
Acquisitions
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| Acquisition of optical specialty stores Luxembourg | 2026-01 | Completed | 24 |
| Acquisition of ten Luxembourg optical and hearing care companies | 2026-01 | Completed | 30 |
| Acquisition of optical specialty stores in Luxembourg | 2026-01 | Completed | 24 |
| Luxembourg acquisition | 2026 | Completed | 27 |
| Integration of Spanish subsidiary | 2025-06 | Completed | 20 |
| Schuldschein issuance | 2025-05 | Completed | 26 |
| Óptica del Penedés acquisition (remaining interest) | 2025 | Completed | 24 |
| Fielmann Vision Insurance Inc. founding | 2025 | Completed | 16 |
| Entry of minority shareholder in Ocumeda AG | 2025 | Completed | 24 |
| Acquisition of Shopko Optical | 2024-07 | Completed | 16 |
| Acquisition of SVS Vision and Shopko Optical | 2024-07 | Completed | 24 |
| Shoptikal Topco, Inc. (Shopko Optical) | 2024-07 | Completed | 16 |
| Óptica del Penedés Call Option Exercise (3×) | 2024 | Completed | 8 |
| Shopko Optical Group acquisition | 2024 | Completed | 24 |
| Shopko Optical Group acquisition | 2024 | Completed | 16 |
| Shopko Optical acquisition | 2024 | Completed | 24 |
| Fielmann Canada Inc. founding | 2024 | Completed | 16 |
| Acquisition of remaining 20% stake in Optica del Penedés | 2024 | Completed | 16 |
| Acquisition of SVS Vision | 2023-09 | Completed | 16 |
| Acquisition in USA | 2023-09 | Completed | 1 |
| SVS Vision acquisition | 2023-09 | Completed | 4 |
| SVS Vision | 2023-09 | Completed | 8 |
| Eyevious Style Inc. und Eye Style of America Ltd. | 2023-06 | Completed | 8 |
| Eyevious Style / Befitting acquisition | 2023-06 | Completed | 8 |
| Befitting e-commerce platform acquisition | 2023-06 | Completed | 4 |
| SVS Vision acquisition | 2023-06 | Completed | 8 |
| Ocumeda AG | 2023-02 | Completed | 8 |
| Ocumeda AG partnership and acquisition (shares) | 2023-01 | Completed | 8 |
| Acquisition of Medical Óptica Audición | 2022-12 | Completed | 3 |
| Acquisition of MFI Group entities | 2022-12 | Completed | 3 |
Divestitures / exits
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| Deconsolidation of Belarus business | 2025-01 | Divested | 24 |
Reported KPIs (as disclosed) (339)#
Figures the company discloses itself in addition to the standard financials; order intake, recurring revenue, user or unit counts, adjusted measures. These “story KPIs” usually slip through standard databases; here they are collected as reported, with no calculation of our own. Important: the definition comes from the company itself and can differ from firm to firm; period and source are stated next to every value.
| Date | Period | KPI | Value / change | Source |
|---|---|---|---|---|
| 2026-08-27 | 2026-H1 | Branches with hearing aid studios | 475 | 30 |
| 2026-08-27 | 2026-H1 | Net debt to LTM EBITDA | 1,1x | 30 |
| 2026-08-27 | 2026-H1 | Customer satisfaction | rund 90% | 30 |
| 2026-08-27 | 2026-H1 | Planned new branches H2 2026 | 33 | 30 |
| 2026-08-27 | 2026-H1 | Planned new branches full year 2026 | 70 | 30 |
| 2026-08-27 | 2026-H1 | Equity ratio | 42,8% | 30 |
| 2026-08-27 | 2026-H1 | EBT margin | 12,7% | 30 |
| 2026-08-27 | 2026-H1 | EBITDA margin | 23,4% | 30 |
| 2026-08-27 | 2026-H1 | Gross margin | 80,1% | 30 |
| 2026-08-27 | 2026-H1 | Adjusted EBT margin | 13,0% | 30 |
| 2026-08-27 | 2026-H1 | Adjusted EBITDA margin | 23,7% | 30 |
| 2026-08-27 | 2026-H1 | Number of branches | 1.299 | 30 |
| 2026-03-31 | 2026-Q1 | Other markets revenue growth | +9,0% | 27 |
| 2026-03-31 | 2026-Q1 | Expected customer satisfaction 2026 | rund 90% | 27 |
| 2026-03-31 | 2026-Q1 | Adjusted EBITDA margin USA prior year | 14,2% | 27 |
| 2026-03-31 | 2026-Q1 | Adjusted EBITDA margin USA | 13,8% | 27 |
| 2026-03-31 | 2026-Q1 | Adjusted EBITDA margin Europe prior year | 25,9% | 27 |
| 2026-03-31 | 2026-Q1 | Adjusted EBITDA Margin Europe | 25,7% | 27 |
| 2026-03-31 | 2026-Q1 | USA Revenue Prior Year | 79 Mio. $ | 27 |
| 2026-03-31 | 2026-Q1 | USA Revenue | 81 Mio. $ | 27 |
| 2026-03-31 | 2026-Q1 | Spain Revenue Growth | +5,2% | 27 |
| 2026-03-31 | 2026-Q1 | Switzerland Revenue Growth | +3,0% | 27 |
| 2026-03-31 | 2026-Q1 | Personnel Cost Ratio Prior Year | 41,4% | 27 |
| 2026-03-31 | 2026-Q1 | Personnel Cost Ratio | 42,2% | 27 |
| 2026-03-31 | 2026-Q1 | Total Branches Prior Year | 1.241 | 27 |
| 2026-03-31 | 2026-Q1 | Total Branches | 1.284 | 27 |
| 2026-03-31 | 2026-Q1 | Luxembourg Acquisition Contribution | 4 Mio. € | 27 |
| 2026-03-31 | 2026-Q1 | Stores with Integrated Hearing Studios Prior Year | 423 | 27 |
| 2026-03-31 | 2026-Q1 | Stores with Integrated Hearing Studios | 460 | 27 |
| 2026-03-31 | 2026-Q1 | Total Distribution Prior Year | 96,6 Mio. € | 27 |
| 2026-03-31 | 2026-Q1 | Total Distribution | 117,6 Mio. € | 27 |
| 2026-03-31 | 2026-Q1 | Dividend Yield | 3,2% | 27 |
| 2026-03-31 | 2026-Q1 | Dividend Per Share Prior Year | 1,15 € | 27 |
| 2026-03-31 | 2026-Q1 | Dividend Per Share | 1,40 € | 27 |
| 2026-03-31 | 2026-Q1 | Germany Austria Organic Growth | +1,5% / +0,8% | 27 |
| 2026-03-31 | 2026-Q1 | Gross Margin Prior Year | 80,5% | 27 |
| 2026-03-31 | 2026-Q1 | Gross margin | 81,1% | 27 |
| 2026-03-31 | 2026-Q1 | Payout Ratio Prior Year | 63% | 27 |
| 2026-03-31 | 2026-Q1 | Payout ratio | 58% | 27 |
| 2026-04-15 | FY2025 | Leverage ratio | 59,9 % | 24 |
| 2026-04-15 | FY2025 | Personnel expenses | 1.018.536 | 24 |
| 2026-04-15 | FY2025 | Employees (annual average) | 23.807 | 24 |
| 2026-04-15 | FY2025 | Material expenses | 488.416 | 24 |
| 2026-04-15 | FY2025 | Liquid funds | 142.547 | 24 |
| 2026-04-15 | FY2025 | Customer satisfaction | 91 % | 24 |
| 2026-04-15 | FY2025 | Equity ratio | 40,2 % | 24 |
| 2026-04-15 | FY2025 | Adjusted EBT margin | +2,2 Prozentpunkte | 24 |
| 2026-04-15 | FY2025 | Adjusted EBITDA margin | 23,8 % | 24 |
| 2026-04-15 | FY2025 | Trainees | 3.771 | 24 |
| 2026-04-15 | FY2025 | Number of branches | 1.262 | 24 |
| 2026-04-15 | FY2025 | Bonds and fixed-term deposits | 79.920 | 24 |
| 2026-04-15 | FY2025 | Units sold (eyewear) | 9.467 | 24 |
| 2026-04-15 | FY2025 | Units sold | 9,5 Mio. € | 24 |
| 2025-09-30 | 2025-Q3 | US Platform 9M | 233 Mio. US-Dollar | 20 |
| 2025-09-30 | 2025-Q3 | Branches | 1.257 | 20 |
| 2025-09-30 | 2025-Q3 | Customer satisfaction | rund 90 % | 20 |
| 2025-09-30 | 2025-Q3 | Hearing systems 9M | 103.000 | 20 |
| 2025-09-30 | 2025-Q3 | Hearing care studios | 430 | 20 |
| 2025-09-30 | 2025-Q3 | Eyewear units sold 9M | 7,0 | 20 |
| 2025-08-28 | 2025-H1 | Target adjusted EBITDA margin 2030 | rund 25 % | 26 |
| 2025-08-28 | 2025-H1 | US business revenue contribution | 156 Mio. $ | 26 |
| 2025-08-28 | 2025-H1 | Schuldschein issuance May 2025 | 275 Mio. € | 26 |
| 2025-08-28 | 2025-H1 | Gross margin H1 2025 | 79,4 % | 26 |
| 2025-08-28 | 2025-H1 | Personnel cost ratio H1 2025 | 40,6 % | 26 |
| 2025-08-28 | 2025-H1 | Organic growth H1 2025 | +4,4 % | 26 |
| 2025-08-28 | 2025-H1 | Branches with hearing care studios 30 June 2025 | 432 | 26 |
| 2025-08-28 | 2025-H1 | Branches 30 June 2025 | 1.251 | 26 |
| 2025-08-28 | 2025-H1 | Customer satisfaction | rund 90 % | 26 |
| 2025-08-28 | 2025-H1 | Group total revenue H1 2025 | 1.224 Mio. € | 26 |
| 2025-08-28 | 2025-H1 | Investments in property, plant and equipment and intangible assets | 37 Mio. € | 26 |
| 2025-08-28 | 2025-H1 | EBITDA margin US | 14,9 % | 26 |
| 2025-08-28 | 2025-H1 | EBITDA margin Europe | 24,8 % | 26 |
| 2025-08-28 | 2025-H1 | Dividend Per Share | 1,15 € | 26 |
| 2025-08-28 | 2025-H1 | Adjusted EBT margin H1 2025 | 12,9 % | 26 |
| 2025-08-28 | 2025-H1 | Adjusted EBITDA margin H1 2025 | 23,7 % | 26 |
| 2025-08-28 | 2025-H1 | Hearing aids sold H1 2025 | rund 69.000 | 26 |
| 2025-08-28 | 2025-H1 | Glasses unit sales H1 2025 | 4,7 Mio. | 26 |
| 2025-03-31 | 2025-Q1 | Global eye care visits annually | rund 900.000 | 19 |
| 2025-03-31 | 2025-Q1 | US business sales | 75 Mio. € | 19 |
| 2025-03-31 | 2025-Q1 | Branches with integrated hearing studios | 423 | 19 |
| 2025-03-31 | 2025-Q1 | Branches | 1.241 | 19 |
| 2025-03-31 | 2025-Q1 | Customer usage Eye Check-Up | Über 170.000 | 19 |
| 2025-03-31 | 2025-Q1 | International revenue share | 39.8 % | 19 |
| 2025-03-31 | 2025-Q1 | Hearing aids unit sales | rund 33.000 | 19 |
| 2025-03-31 | 2025-Q1 | Eyewear unit sales | 2.3 | 19 |
| 2025-04-17 | FY2024 | lease interest expense | 18.810 | 16 |
| 2025-04-17 | FY2024 | Leverage ratio | 61,5 % | 16 |
| 2025-04-17 | FY2024 | Shopko Optical transaction costs | Tsd. € 2.708 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical property, plant and equipment | Tsd. € 8.748 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical Revenue partial year | Tsd. € 85.172 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical Net income partial year | Tsd. € 2.321 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical brand | Tsd. € 47.278 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical customer base | Tsd. € 41.973 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical purchase price | Tsd. € 278.523 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical intangible assets | Tsd. € 89.251 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical Hypothetical full year revenue | Tsd. € 171.426 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical Hypothetical full year net income | Tsd. € 4.794 | 16 |
| 2025-04-17 | FY2024 | Shopko Optical goodwill | Tsd. € 141.368 | 16 |
| 2025-04-17 | FY2024 | gross margin | 80,0 % | 16 |
| 2025-04-17 | FY2024 | Personnel expenses ratio | 43,6 % | 16 |
| 2025-04-17 | FY2024 | Personnel expenses - social contributions and pensions | 148.112 | 16 |
| 2025-04-17 | FY2024 | Personnel expenses - wages and salaries | 839.296 | 16 |
| 2025-04-17 | FY2024 | Organic growth | 5 % oder mehr | 16 |
| 2025-04-17 | FY2024 | Branches | 1.240 | 16 |
| 2025-04-17 | FY2024 | Employees at reporting date | 24.363 | 16 |
| 2025-04-17 | FY2024 | Employees full-time equivalents | 18.132 | 16 |
| 2025-04-17 | FY2024 | Employees annual average | 23.716 | 16 |
| 2025-04-17 | FY2024 | Employees | 24.363 | 16 |
| 2025-04-17 | FY2024 | Lease payments | 119.397 | 16 |
| 2025-04-17 | FY2024 | Customer satisfaction | 91 % | 16 |
| 2025-04-17 | FY2024 | Hearing systems sold | 128.000 | 16 |
| 2025-04-17 | FY2024 | Return on equity | 16,9 % | 16 |
| 2025-04-17 | FY2024 | Equity ratio | 38,5 % | 16 |
| 2025-04-17 | FY2024 | EBT margin | 9,7 % | 16 |
| 2025-04-17 | FY2024 | EBT margin | 9,6% | 16 |
| 2025-04-17 | FY2024 | EBITDA margin 2024 | 20,8% | 16 |
| 2025-04-17 | FY2024 | EBITDA margin | 20,8 % | 16 |
| 2025-04-17 | FY2024 | EBITDA margin | 20,3% | 16 |
| 2025-04-17 | FY2024 | Adjusted EBT margin | 10,6 % | 16 |
| 2025-04-17 | FY2024 | Adjusted EBT margin | 9,8% | 16 |
| 2025-04-17 | FY2024 | Adjusted EBITDA margin 2024 | 21,7% | 16 |
| 2025-04-17 | FY2024 | Adjusted EBITDA margin | 21,7 % | 16 |
| 2025-04-17 | FY2024 | Adjusted EBITDA margin | 20,2% | 16 |
| 2025-04-17 | FY2024 | Eyewear units sold | 9.286 | 16 |
| 2024-09-30 | 2024-Q3 | Organic growth 9M | 4,9 % | 12 |
| 2024-09-30 | 2024-Q3 | Adjusted EBITDA margin US | 7,3 % | 12 |
| 2024-09-30 | 2024-Q3 | Adjusted EBITDA margin Europe | 23,6 % | 12 |
| 2024-09-30 | 2024-Q3 | Eye care services (9M) | 675.000 | 12 |
| 2024-09-30 | 2024-Q3 | Growth from US acquisitions | 7,8 % | 12 |
| 2024-09-30 | 2024-Q3 | US locations | 227 | 12 |
| 2024-09-30 | 2024-Q3 | US employees | 1.800 | 12 |
| 2024-09-30 | 2024-Q3 | gross margin | 79,6 % | 12 |
| 2024-09-30 | 2024-Q3 | Branches | 1.234 | 12 |
| 2024-09-30 | 2024-Q3 | Hearing systems | 95.000 | 12 |
| 2024-09-30 | 2024-Q3 | Hearing-aid studios | 402 | 12 |
| 2024-09-30 | 2024-Q3 | Total employees | 24.673 | 12 |
| 2024-09-30 | 2024-Q3 | Eyewear unit sales | 6,8 | 12 |
| 2024-09-30 | 2024-Q3 | Eye check-up locations | 400 | 12 |
| 2024-09-30 | 2024-Q3 | Eye check-up customers | 70.000 | 12 |
| 2024-08-29 | 2024-H1 | Branches | 1.085 | 18 |
| 2024-08-29 | 2024-H1 | Hearing-aid studios | 398 | 18 |
| 2024-08-29 | 2024-H1 | EBT margin H1 | 11,6% | 18 |
| 2024-08-29 | 2024-H1 | EBITDA margin H1 | 21,7% | 18 |
| 2024-08-29 | 2024-H1 | Dividend per share | 1,00 € | 18 |
| 2024-08-29 | 2024-H1 | Employees | 22.844 | 18 |
| 2024-08-29 | 2024-H1 | Payout ratio | 66% | 18 |
| 2024-08-29 | 2024-H1 | Units sold | 4,5 Millionen Brillen | 18 |
| 2024-03-31 | 2024-Q1 | Gross profit | 20,1% | 11 |
| 2024-03-31 | 2024-Q1 | Branches | 1.078 | 11 |
| 2024-03-31 | 2024-Q1 | Employees | 22.982 | 11 |
| 2024-03-31 | 2024-Q1 | Customer satisfaction | über 90 Prozent | 11 |
| 2024-03-31 | 2024-Q1 | Hearing-aid locations | 393 | 11 |
| 2024-03-31 | 2024-Q1 | Planned eyewear unit sales | rund 9,2 Millionen | 11 |
| 2024-03-31 | 2024-Q1 | EBT margin | 11,6% | 11 |
| 2024-03-31 | 2024-Q1 | EBITDA margin | 21,7% | 11 |
| 2024-03-31 | 2024-Q1 | Cost ratio | 44,3% | 11 |
| 2024-04-18 | FY2023 | Branches audited for corruption risk | 139 | 1 |
| 2024-04-18 | FY2023 | Data protection enquiry target achievement | 99,7 % | 1 |
| 2024-04-18 | FY2023 | Inventories - Work in progress | 18.922 | 8 |
| 2024-04-18 | FY2023 | Inventories - Raw, auxiliary and operating materials | 669 | 8 |
| 2024-04-18 | FY2023 | Inventories - Finished goods and merchandise | 205.149 | 8 |
| 2024-04-18 | FY2023 | Leverage ratio | 39,3% | 8 |
| 2024-04-18 | FY2023 | Energy consumption reduction | 5,6 | 1 |
| 2024-04-18 | FY2023 | Tax rate 2022 | 31,6 | 8 |
| 2024-04-18 | FY2023 | Tax rate | 32,6 | 8 |
| 2024-04-18 | FY2023 | Other non-current financial assets | 5.683 | 8 |
| 2024-04-18 | FY2023 | Other non-current provisions | 5.985 | 8 |
| 2024-04-18 | FY2023 | Other products and services revenue | 46 | 8 |
| 2024-04-18 | FY2023 | Sunglasses revenue | 84 | 8 |
| 2024-04-18 | FY2023 | Protective eyewear for Hanseatic Help Turkey/Syria | 10.000 | 1 |
| 2024-04-18 | FY2023 | Training status of project-responsible employees | 100 % | 1 |
| 2024-04-18 | FY2023 | Provisions in merchandise area | 4.670 | 8 |
| 2024-04-18 | FY2023 | Decommissioning obligations | 8.137 | 8 |
| 2024-04-18 | FY2023 | Pre-tax return 2022 | 9,1 | 8 |
| 2024-04-18 | FY2023 | Pre-tax return | 9,8 | 8 |
| 2024-04-18 | FY2023 | Online appointments | 16,6 Millionen | 8 |
| 2024-04-18 | FY2023 | Branches prior year | 968 | 1 |
| 2024-04-18 | FY2023 | Branches 2022 | 968 | 8 |
| 2024-04-18 | FY2023 | Branches 2021 | 913 | 8 |
| 2024-04-18 | FY2023 | Branches 2020 | 870 | 8 |
| 2024-04-18 | FY2023 | Branches 2019 | 776 | 8 |
| 2024-04-18 | FY2023 | Branches | 1.086 | 8 |
| 2024-04-18 | FY2023 | Branches | 1.086 | 1 |
| 2024-04-18 | FY2023 | Net return 2022 | 6,2 | 8 |
| 2024-04-18 | FY2023 | Net return | 6,6 | 8 |
| 2024-04-18 | FY2023 | Employees excl. trainees | 19.354 | 1 |
| 2024-04-18 | FY2023 | Employees total | 23.412 | 1 |
| 2024-04-18 | FY2023 | Employees prior year | 22.631 | 1 |
| 2024-04-18 | FY2023 | Employees full-time | 14.766 | 1 |
| 2024-04-18 | FY2023 | Employees part-time | 6.823 | 1 |
| 2024-04-18 | FY2023 | Employees 2022 | 22.631 | 8 |
| 2024-04-18 | FY2023 | Employees 2021 | 22.028 | 8 |
| 2024-04-18 | FY2023 | Employees 2020 | 21.853 | 8 |
| 2024-04-18 | FY2023 | Employees 2019 | 20.397 | 8 |
| 2024-04-18 | FY2023 | Employees (FTEs) | 17.317 | 8 |
| 2024-04-18 | FY2023 | Employees | 23.412 | 8 |
| 2024-04-18 | FY2023 | Market share Austria (revenue) | 24% | 8 |
| 2024-04-18 | FY2023 | Market share Austria (unit sales) | 33% | 8 |
| 2024-04-18 | FY2023 | Market share Spain (revenue) | rund 10% | 8 |
| 2024-04-18 | FY2023 | Market share Spain (unit sales) | 9% | 8 |
| 2024-04-18 | FY2023 | Market share Switzerland (revenue) | 19% | 8 |
| 2024-04-18 | FY2023 | Market share Switzerland (unit sales) | 44% | 8 |
| 2024-04-18 | FY2023 | Market share Germany (revenue) | 23% | 8 |
| 2024-04-18 | FY2023 | Market share Germany (unit sales) | 55% | 8 |
| 2024-04-18 | FY2023 | Liquid funds | 58.926 | 8 |
| 2024-04-18 | FY2023 | Deferred tax liabilities | 54.783 | 8 |
| 2024-04-18 | FY2023 | Deferred tax assets | 25.227 | 8 |
| 2024-04-18 | FY2023 | Long-term financial assets | 8.066 | 8 |
| 2024-04-18 | FY2023 | Lab tests eyeglass models | 13.252 | 1 |
| 2024-04-18 | FY2023 | LED conversions | 70 | 1 |
| 2024-04-18 | FY2023 | Customer satisfaction | 92% | 8 |
| 2024-04-18 | FY2023 | Corrective eyewear revenue | 1.543 | 8 |
| 2024-04-18 | FY2023 | Contact lenses and care products revenue | 167 | 8 |
| 2024-04-18 | FY2023 | Anniversary provisions | 6.960 | 8 |
| 2024-04-18 | FY2023 | International market share revenue | 625,3 | 8 |
| 2024-04-18 | FY2023 | Hearing acoustics revenue | 129 | 8 |
| 2024-04-18 | FY2023 | Total tax expense group | 63.076 | 8 |
| 2024-04-18 | FY2023 | Planned eye check-up locations by end of 2024 | 400 | 1 |
| 2024-04-18 | FY2023 | Planned eye check-up customers 2024 | 100.000 | 1 |
| 2024-04-18 | FY2023 | Trees planted total | 1,7 Millionen | 1 |
| 2024-04-18 | FY2023 | Free Cashflow 2022 | 85,1 (EUR Mio. €) | 8 |
| 2024-04-18 | FY2023 | Free Cashflow | 139,5 (EUR Mio. €) | 8 |
| 2024-04-18 | FY2023 | Women's share first three levels below board | 40% | 8 |
| 2024-04-18 | FY2023 | Women's share board | 25% | 8 |
| 2024-04-18 | FY2023 | Women's share supervisory board | 37,5% | 8 |
| 2024-04-18 | FY2023 | Women's share total workforce | 70,3% | 8 |
| 2024-04-18 | FY2023 | Public funding | 0,2 | 1 |
| 2024-04-18 | FY2023 | Financial assets with fixed maturity over three months | 22.908 | 8 |
| 2024-04-18 | FY2023 | Engagement Index | 3,82 | 1 |
| 2024-04-18 | FY2023 | Return on Equity after Tax 2022 | 12,9 | 8 |
| 2024-04-18 | FY2023 | Return on Equity after Tax | 14,7 | 8 |
| 2024-04-18 | FY2023 | Group Equity Ratio 2022 | 48,5 | 8 |
| 2024-04-18 | FY2023 | Group Equity Ratio 2021 | 50,3 | 8 |
| 2024-04-18 | FY2023 | Group Equity Ratio 2020 | 50,1 | 8 |
| 2024-04-18 | FY2023 | Group Equity Ratio 2019 | 53,2 | 8 |
| 2024-04-18 | FY2023 | Group Equity Ratio | 46,6 | 8 |
| 2024-04-18 | FY2023 | Equity ratio | 46,6% | 8 |
| 2024-04-18 | FY2023 | EBITDA Margin 2022 | 19,3 (EUR %) | 8 |
| 2024-04-18 | FY2023 | EBITDA margin | 20,8 (EUR %) | 8 |
| 2024-04-18 | FY2023 | E-Commerce Revenue Growth | +17% | 8 |
| 2024-04-18 | FY2023 | E-Commerce Revenue | mehr als 100 Millionen Euro | 8 |
| 2024-04-18 | FY2023 | E-Commerce Revenue | 100 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Austria 2022 | 2,4 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Austria | 2,6 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch USA | 1,2 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Spain 2022 | 1,5 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Spain | 1,7 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Switzerland 2022 | 5,6 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Switzerland | 5,2 | 8 |
| 2024-04-18 | FY2023 | Avg. Annual Revenue per Branch Germany 2022 | 2,3 | 8 |
| 2024-04-18 | FY2023 | Avg. annual revenue per branch (Germany) | 2,5 | 8 |
| 2024-04-18 | FY2023 | Average employees | 22.974 | 8 |
| 2024-04-18 | FY2023 | Dividend per share 2022 | 0,75 | 8 |
| 2024-04-18 | FY2023 | Dividend per share 2021 | 1,50 | 8 |
| 2024-04-18 | FY2023 | Dividend per share 2020 | 1,20 | 8 |
| 2024-04-18 | FY2023 | Dividend per share 2019 | – | 8 |
| 2024-04-18 | FY2023 | Dividend Per Share | 1,00 | 8 |
| 2024-04-18 | FY2023 | Digital usage | 32 Millionen Mal | 8 |
| 2024-04-18 | FY2023 | Data privacy requests | 20.734 | 1 |
| 2024-04-18 | FY2023 | Cash flow per share 2022 | 2,92 (EUR €) | 8 |
| 2024-04-18 | FY2023 | Cash flow per share 2021 | 4,13 (EUR €) | 8 |
| 2024-04-18 | FY2023 | Cash flow per share 2020 | 3,32 (EUR €) | 8 |
| 2024-04-18 | FY2023 | Cash flow per share 2019 | 3,59 (EUR €) | 8 |
| 2024-04-18 | FY2023 | Cash flow per share | 3,37 (EUR €) | 8 |
| 2024-04-18 | FY2023 | Eyewear unit sales 2022 | 8.582 | 8 |
| 2024-04-18 | FY2023 | Eyewear unit sales 2021 | 8.291 | 8 |
| 2024-04-18 | FY2023 | Eyewear sales 2020 | 7.264 | 8 |
| 2024-04-18 | FY2023 | Eyewear sales 2019 | 8.277 | 8 |
| 2024-04-18 | FY2023 | Eyewear unit sales | 8.891 | 8 |
| 2024-04-18 | FY2023 | Employee shareholders | rund 70% | 8 |
| 2024-04-18 | FY2023 | Apprentices Germany | 3.679 | 8 |
| 2024-04-18 | FY2023 | Apprentices 2022 | 4.107 | 8 |
| 2024-04-18 | FY2023 | Apprentices 2021 | 4.374 | 8 |
| 2024-04-18 | FY2023 | Apprentices 2020 | 4.516 | 8 |
| 2024-04-18 | FY2023 | Apprentices 2019 | 4.268 | 8 |
| 2024-04-18 | FY2023 | Trainees | 4.058 | 8 |
| 2024-04-18 | FY2023 | Trainees | 4.058 | 1 |
| 2024-04-18 | FY2023 | International revenue share | 35 | 8 |
| 2024-04-18 | FY2023 | Eye check-up examinations conducted | 20.000 | 1 |
| 2024-04-18 | FY2023 | Sick leave rate Germany | 6,8 | 1 |
| 2024-04-18 | FY2023 | Number of locations Austria | 44 | 8 |
| 2024-04-18 | FY2023 | Number of locations Spain | 123 | 8 |
| 2024-04-18 | FY2023 | Number of locations Switzerland | 44 | 8 |
| 2024-04-18 | FY2023 | Number of locations North America | 82 | 8 |
| 2024-04-18 | FY2023 | Number of locations Germany | 619 | 8 |
| 2024-04-18 | FY2023 | Number of branches | 1.209 | 8 |
| 2024-04-18 | FY2023 | Share of audited locations | 13 % | 1 |
| 2024-04-18 | FY2023 | Share of audited suppliers | 100 % | 1 |
| 2024-04-18 | FY2023 | Share of audited eyewear models | 100 % | 1 |
| 2024-04-18 | FY2023 | Share of advertising objections | 13.000 | 1 |
| 2024-04-18 | FY2023 | Requests answered within 20 days | 3,6 % | 1 |
| 2024-04-18 | FY2023 | Requests answered within 10 days | 11,3 % | 1 |
| 2024-04-18 | FY2023 | Requests answered within 5 days | 84,3 % | 1 |
| 2024-04-18 | FY2023 | Requests answered 21-30 days | 0,4 % | 1 |
| 2024-04-18 | FY2023 | Unit sales Austria | 393.000 Brillen | 8 |
| 2024-04-18 | FY2023 | Unit sales Spain | 567.000 Brillen | 8 |
| 2024-04-18 | FY2023 | Unit sales Switzerland | 436.000 Brillen | 8 |
| 2024-04-18 | FY2023 | Unit sales hearing acoustics 2022 | 106,2 Tausend | 8 |
| 2024-04-18 | FY2023 | Unit sales hearing acoustics | 119,0 Tausend | 8 |
| 2024-04-18 | FY2023 | Unit sales Germany | 6,7 Millionen Brillen | 8 |
| 2024-04-18 | FY2023 | Units sold | 9,0 Millionen Brillen | 8 |
| 2023-09-30 | 2023-Q3 | Spain nine-month comparison growth | +42,4% | 4 |
| 2023-09-30 | 2023-Q3 | Switzerland nine-month comparison growth | +6,0% | 4 |
| 2023-09-30 | 2023-Q3 | Organic growth Q3 | +10% | 4 |
| 2023-09-30 | 2023-Q3 | Employees | 23.870 | 4 |
| 2023-09-30 | 2023-Q3 | Hearing-aid studios | 379 | 4 |
| 2023-09-30 | 2023-Q3 | Feldmann-Augen-Check-Up registered customers | mehr als 14.000 | 4 |
| 2023-09-30 | 2023-Q3 | Digital sales channels growth | +16,2% | 4 |
| 2023-09-30 | 2023-Q3 | Capex nine-month comparison | 219,4 Millionen € | 4 |
| 2023-09-30 | 2023-Q3 | Eyewear unit sales Q3 | 2,27 Millionen | 4 |
| 2023-09-30 | 2023-Q3 | Eyewear unit sales nine-month comparison | 6,64 Millionen | 4 |
| 2023-09-30 | 2023-Q3 | External revenue Q3 | 601,6 Millionen € | 4 |
| 2023-09-30 | 2023-Q3 | External revenue nine-month comparison | 1,73 Milliarden € | 4 |
| 2023-09-30 | 2023-Q3 | Trainees | 4.289 | 4 |
| 2023-09-30 | 2023-Q3 | International markets growth | +20,8% | 4 |
| 2023-09-30 | 2023-Q3 | Number of branches | 1.075 | 4 |
| 2023-09-30 | 2023-Q3 | Acquisition growth contribution Q3 | +3,8% | 4 |
| 2023-08-24 | 2023-H1 | International revenue growth like-for-like | 14,3 Prozent | 10 |
| 2023-08-24 | 2023-H1 | International revenue growth | 21,5 Prozent | 10 |
| 2023-08-24 | 2023-H1 | Germany revenue growth | 10,5 Prozent | 10 |
| 2023-08-24 | 2023-H1 | SVS Vision revenue 2022 | mehr als 100 Millionen US-Dollar | 10 |
| 2023-08-24 | 2023-H1 | Employees | 22.222 | 10 |
| 2023-08-24 | 2023-H1 | Group revenue Q2 | 493,2 Millionen Euro | 10 |
| 2023-08-24 | 2023-H1 | Total Distribution | 63,0 Millionen € | 10 |
| 2023-08-24 | 2023-H1 | E-commerce revenue growth | 28 Prozent | 10 |
| 2023-08-24 | 2023-H1 | Dividend per share | 0,75 € | 10 |
| 2023-08-24 | 2023-H1 | Eyewear unit sales Q2 | 2,2 Millionen | 10 |
| 2023-08-24 | 2023-H1 | Eyewear unit sales | 4,4 Millionen | 10 |
| 2023-08-24 | 2023-H1 | External revenue Q2 | 573,2 Millionen Euro | 10 |
| 2023-08-24 | 2023-H1 | External revenue | 1,13 Milliarden € | 10 |
| 2023-08-24 | 2023-H1 | Trainees | 3.681 | 10 |
| 2023-08-24 | 2023-H1 | Payout ratio | 60,3 Prozent | 10 |
| 2023-03-31 | 2023-Q1 | locations with hearing acoustics | 359 | 3 |
| 2023-03-31 | 2023-Q1 | Branches | 977 | 3 |
| 2023-03-31 | 2023-Q1 | Employees | 22.354 | 3 |
| 2023-03-31 | 2023-Q1 | Investments in property, plant and equipment and intangible assets | 30,7 Millionen € | 3 |
| 2023-03-31 | 2023-Q1 | Dividend Per Share | 0,75 € | 3 |
| 2023-03-31 | 2023-Q1 | external sales (incl. VAT and inventory changes) | 556 Millionen € | 3 |
| 2023-03-31 | 2023-Q1 | Payout ratio | 61 Prozent | 3 |
Guidance Tracking (latest per metric/period · 14/27)#
All management forecasts (guidance) and their later outcome. Types: fiscal-year targets as well as quarterly/half-year targets; per metric and period the most recent statement applies, older versions can be expanded. The status is checked automatically against the actuals reported later: open (period still running), met, beaten, missed. For ranges (“X to Y”) reaching the range counts. Logged neutrally, no estimate of our own, no assessment.
Actuals: revenue in €m · ratios in %
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | 2026-08-27 | EBITDA (adjusted) | 22–23% | – | pending | confirmed | 30 |
| FY2026 | 2026-08-27 | adj. operating income | 12% | – | pending | confirmed | 30 |
| FY2026 | 2026-04-15 | EBITDA | 590–610 | – | pending | initiated | 24 |
| FY2026 | 2026-04-15 | EBITDA margin | 23% | – | pending | confirmed | 24 |
| FY2026 | 2026-04-15 | group revenue | 2.55–2.6 | – | pending | initiated | 24 |
| FY2026 | 2026-04-15 | adjusted EBT margin | 12–13% | – | pending | confirmed | 24 |
| FY2026 | 2026-03-31 | Revenue | 2,500–2,550 | – | pending | confirmed | 30 |
| FY2026 | 2026-03-31 | Gross margin (non-GAAP) | 23% | – | pending | confirmed | 27 |
| FY2025 | 2025-08-28 | Units sold | 5–9 | – | – | confirmed | 20 |
| FY2025 | 2025-08-28 | Group total output | 2,000–5,000 | – | – | confirmed | 26 |
| FY2025 | 2025-04-17 | EBITDA | 580 | 559.8 | miss | confirmed | 20 |
| FY2025 | 2025-04-17 | Group total revenue | 2,000–5,000 | – | – | confirmed | 20 |
| FY2025 | 2025-04-17 | Eyewear units sold | 5–9 | – | – | raised | 16 |
| FY2025 | 2024-08-29 | EBITDA margin | 24% | 23 | miss | confirmed | 20 |
| FY2024 | 2024-09-30 | EBITDA margin | 10% | 20.8 | beat | confirmed | 12 |
| FY2024 | 2024-08-29 | Revenue | 2,000–3,000 | 2,266.9 | in line | confirmed | 18 |
| FY2024 | 2024-04-18 | group revenue | 2 | – | – | confirmed | 8 |
| FY2024 | 2024-04-18 | Units sold | 2–9 | – | – | confirmed | 8 |
| FY2024 | 2024-04-18 | Customer satisfaction | 90 | – | – | confirmed | 8 |
| FY2024 | 2024-03-31 | EBITDA | ähnliche oder leicht höhere EBITDA-Marge wie 2023 | 471.1 | – | confirmed | 11 |
| FY2023 | 2023-09-30 | Revenue | 2,000–3,000 | 1,970.9 | miss | initiated | 4 |
| FY2023 | 2023-09-30 | EBITDA | 400 | 401 | beat | – | 4 |
| FY2023 | 2023-09-30 | operating_income | 190 | – | – | initiated | 4 |
| FY2023 | 2023-03-31 | EBITDA growth (YoY) | 20–21% | – | – | initiated | 3 |
| FY2023 | 2023-03-31 | Prescription eyewear volume | 4–8% | – | – | initiated | 3 |
| FY2023 | 2023-03-31 | group revenue | 1–94 | – | – | initiated | 3 |
| FY2023 | 2023-03-31 | EBT margin | 9–11% | – | – | initiated | 3 |
Development#
A condensed summary per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. Most recent period first, grouped by year; each text is written from the original report of that period, superscript numbers lead to the source.
FY2026
In the first half of fiscal year 2026, Fielmann Group AG grew consolidated revenue 1.8% to approximately EUR 1.25 billion (currency-adjusted +2.3%), with Q1 contributing EUR 613.0 million and Q2 EUR 634.9 million 27 30. The adjusted EBITDA margin held at 23.7% and the adjusted EBT margin at 13.0% for H1/2026, supported by cost discipline and gross margin expansion to 80.1% 30. International markets accelerated in H1, led by Spain at +7.4% and the United States at +3.3% currency-adjusted, while 37 new locations were opened toward a full-year target of 70 -- triple the 2025 pace 30. Free cash flow declined to EUR 121 million from EUR 199 million in the prior-year period, reflecting a temporary increase in net working capital and higher capital expenditure 30. Full-year 2026 guidance of revenue EUR 2.50-2.55 billion, adjusted EBITDA margin 22-23%, and adjusted EBT margin approximately 12% was confirmed at the H1 report 30.
FY2025
Fielmann Group AG recorded FY2025 group revenue of €2,435.3 million, an increase of 7.4% year-over-year and the highest level in the company's history 124. Adjusted EBITDA grew 18% to €580.6 million with an adjusted EBITDA margin of 24%, while net income rose 33% to a record €205.5 million 24. Free cash flow increased by €304.3 million to €383.2 million, supported by operating cash flow of €496.0 million 124. The US platform – comprising the integrated SVS Vision and Shopko Optical businesses – expanded its adjusted EBITDA margin by 6.3 percentage points to 16.2%, and the German market share reached a record 57% 24. The year concluded the Vision 2025 strategy and launched Vision 2035, which targets group revenue of approximately €4 billion and an adjusted EBITDA margin of approximately 25% by 2030 24.
FY2024
Fielmann Group AG recorded FY2024 group revenue of €2,266.9m, up 14.9% year-on-year, with approximately 7% from organic growth and approximately 8% from the acquisition of Shopko Optical, which closed on 1 July 2024, exceeding the group's stated target of more than €2bn (16, 124). Adjusted EBITDA rose 23.3% to €491m, with the adjusted EBITDA margin expanding approximately 1.5 percentage points to 21.7% at group level and approximately 2.1 percentage points to 22.8% in Europe (16). Net income grew 20.7% to €154.2m and diluted EPS increased to €1.81 from €1.49 in the prior year, supported by operating cash flow rising 45.0% to €410.1m (16, 124). The Shopko Optical acquisition for approximately €278.5m shifted the group balance sheet from a net cash position of €39.7m at mid-year to net debt of €219.6m at year-end (126, 124). The supervisory board proposed a 15% dividend increase to €1.15 per share for FY2024, and the group indicated that its Vision 2025 adjusted EBITDA margin targets are on track to be achieved (16).
FY2023
Group revenue grew 11.9% to EUR 1,971 million in FY2023 (116), while EBITDA rose 20.8% to EUR 410.1 million and the EBITDA margin expanded from 19.3% to 20.8% (8). Adjusted operating income reached EUR 192.8 million, free cash flow EUR 198.8 million, and operating cash flow improved 15.4% to EUR 282.8 million (116). The year's principal strategic action was North American market entry, completed through the acquisition of Eyevious Style/Befitting in June 2023 and SVS Vision -- 82 optical stores across nine US states -- effective 1 September 2023, alongside earlier consolidation of Medical Óptica Audición (Spain) and Ocumeda (Switzerland) (8). International revenue grew 23.5% to EUR 625.3 million, representing 35% of group sales, e-commerce surpassed EUR 100 million for the first time at +17%, and the German corrective eyewear market share reached a record 55% (8). At year-end the net balance sheet position shifted to net debt of EUR 74.2 million from net cash of EUR 101.4 million at mid-year, reflecting EUR 268.4 million in total investments including M&A (116, 8).
Sources: official investor relations documents#
All original documents used, with type (e.g. quarterly, half-year, annual report), publication date and a direct link to the filing (EDINET/SEC/IR). Every superscript number in the report points to an entry in this list; so every figure can be traced back to its place in the original.
| # | Document type | Published | Link |
|---|---|---|---|
| #10 / #110 | IR-Half | – | Open |
| #3 / #103 | IR-Quarter | 2023-03-31 | Open |
| #4 / #104 | IR-Quarter | 2023-09-30 | Open |
| #11 / #111 | IR-Quarter | 2024-03-31 | Open |
| #1 | IR-Report | 2024-04-18 | Open |
| #8 / #108 | IR-Annual | 2024-04-18 | Open |
| #18 / #118 | IR-Half | 2024-08-29 | Open |
| #12 / #112 | IR-Quarter | 2024-09-30 | Open |
| #19 / #119 | IR-Quarter | 2025-03-31 | Open |
| #16 / #116 | IR-Annual | 2025-04-17 | Open |
| #26 / #126 | IR-Half | 2025-08-28 | Open |
| #20 / #120 | IR-Quarter | 2025-09-30 | Open |
| #27 / #127 | IR-Quarter | 2026-03-31 | Open |
| #24 / #124 | IR-Annual | 2026-04-15 | Open |
| #30 / #130 | IR-Half | 2026-08-27 | Open |
FAQ#
Is there a management forecast (guidance) for FY2026?
Yes. Management has issued targets for FY2026, including EBITDA (adjusted). The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Does Fielmann GROUP AG pay a dividend?
The filings report on the dividend; most recent entry: dividends paid 3,2% (2026-Q1) (as reported, no assessment of our own). Details with source links are in the report chapters.
Where can I find the official investor relations documents of Fielmann GROUP AG?
The sources chapter links all 29 original filings used (IR documents) with type, publication date and a direct link; every figure in the report carries a source number.